SEAFORD NIFEDIPINE AND LIDOCAINE HYDROCHLORIDE CREAM DIN 02548283
Health Canada record
| Active ingredient(s) | NIFEDIPINE 0.3 %; LIDOCAINE HYDROCHLORIDE 1.5 % |
|---|---|
| Dosage form | Cream |
| Route | Rectal |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C05AD01 LIDOCAINE |
| Original market date | 02-Feb-2026 |
| Current status date | 02-Feb-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Seaford Pharmaceuticals Inc — licence 100212, currently licensed, last inspection rating C (2024-06-18).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NIFEDIPINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02323931 | ADALAT OROS | BAYER INC | Tablet (Extended-Release) | NIFEDIPINE 30 MG | Approved |
| 02155907 | ADALAT XL | BAYER INC | Tablet (Extended-Release) | NIFEDIPINE 30 MG | Marketed |
| 02511460 | AG-NIFEDIPINE ER | ANGITA PHARMA INC. | Tablet (Extended-Release) | NIFEDIPINE 60 MG | Marketed |
| 02511711 | JAMP NIFEDIPINE ER | JAMP PHARMA CORPORATION | Tablet (Extended-Release) | NIFEDIPINE 60 MG | Marketed |
| 02511649 | M-NIFEDIPINE ER | MANTRA PHARMA INC | Tablet (Extended-Release) | NIFEDIPINE 60 MG | Marketed |
| 02509296 | MAR-NIFEDIPINE ER | MARCAN PHARMACEUTICALS INC | Tablet (Extended-Release) | NIFEDIPINE 60 MG | Approved |
| 02321149 | MYLAN-NIFEDIPINE EXTENDED RELEASE | MYLAN PHARMACEUTICALS ULC | Tablet (Extended-Release) | NIFEDIPINE 60 MG | Marketed |
| 02349167 | MYLAN-NIFEDIPINE EXTENDED RELEASE | MYLAN PHARMACEUTICALS ULC | Tablet (Extended-Release) | NIFEDIPINE 30 MG | Marketed |
| 00725110 | NIFEDIPINE | AA PHARMA INC | Capsule | NIFEDIPINE 5 MG | Marketed |
| 00755907 | NIFEDIPINE | AA PHARMA INC | Capsule | NIFEDIPINE 10 MG | Marketed |
| 02421658 | NIFEDIPINE ER | PRO DOC LIMITEE | Tablet (Extended-Release) | NIFEDIPINE 60 MG | Marketed |
| 02441403 | NIFEDIPINE ER | PRO DOC LIMITEE | Tablet (Extended-Release) | NIFEDIPINE 20 MG | Approved |
| 02416301 | PMS-NIFEDIPINE ER | PHARMASCIENCE INC | Tablet (Extended-Release) | NIFEDIPINE 60 MG | Marketed |
| 02533332 | PMSC-NIFEDIPINE ER | PHARMASCIENCE INC | Tablet (Extended-Release) | NIFEDIPINE 30 MG | Marketed |
| 02155869 | ADALAT | BAYER INC | Capsule | NIFEDIPINE 5 MG | Cancelled Post Market |
| 02155877 | ADALAT - CAP 10MG | BAYER INC | Capsule | NIFEDIPINE 10 MG | Cancelled Post Market |
| 00557633 | ADALAT CAP 10MG | MILES CANADA INC. - PHARMACEUTICAL DIVISION | Capsule | NIFEDIPINE 10 MG | Cancelled Post Market |
| 00613258 | ADALAT CAP 5MG | MILES CANADA INC. - PHARMACEUTICAL DIVISION | Capsule | NIFEDIPINE 5 MG | Cancelled Post Market |
| 02323923 | ADALAT OROS | BAYER INC | Tablet (Extended-Release) | NIFEDIPINE 20 MG | Cancelled Pre Market |
| 02323958 | ADALAT OROS | BAYER INC | Tablet (Extended-Release) | NIFEDIPINE 60 MG | Cancelled Pre Market |
| 02155885 | ADALAT P.A.10 -SRT 10MG | BAYER INC | Tablet (Extended-Release) | NIFEDIPINE 10 MG | Cancelled Post Market |
| 02155893 | ADALAT P.A.20 -SRT 20MG | BAYER INC | Tablet (Extended-Release) | NIFEDIPINE 20 MG | Cancelled Post Market |
| 00692727 | ADALAT PA 10 TAB 10MG | MILES CANADA INC. - PHARMACEUTICAL DIVISION | Tablet | NIFEDIPINE 10 MG | Cancelled Post Market |
| 00692735 | ADALAT PA 20 | MILES CANADA INC. - PHARMACEUTICAL DIVISION | Tablet | NIFEDIPINE 20 MG | Cancelled Post Market |
| 02155990 | ADALAT XL | BAYER INC | Tablet (Extended-Release) | NIFEDIPINE 60 MG | Cancelled Post Market |
| 02237618 | ADALAT XL | BAYER INC | Tablet (Extended-Release) | NIFEDIPINE 20 MG | Cancelled Post Market |
| 02313782 | ADALAT XL PLUS | BAYER INC | Tablet (Delayed-Release); Kit; Tablet (Extended-Release) | NIFEDIPINE 60 MG; ACETYLSALICYLIC ACID 81 MG | Cancelled Post Market |
| 02313774 | ADALAT XL PLUS | BAYER INC | Tablet (Delayed-Release); Tablet (Extended-Release); Kit | NIFEDIPINE 30 MG; ACETYLSALICYLIC ACID 81 MG | Cancelled Post Market |
| 01913131 | ADALAT XL TAB 30MG | MILES CANADA INC. - PHARMACEUTICAL DIVISION | Tablet (Extended-Release) | NIFEDIPINE 30 MG | Cancelled Post Market |
| 01913158 | ADALAT XL TAB 60MG | MILES CANADA INC. - PHARMACEUTICAL DIVISION | Tablet (Extended-Release) | NIFEDIPINE 60 MG | Cancelled Post Market |
| 02181525 | APO-NIFED PA | APOTEX INC | Tablet (Extended-Release) | NIFEDIPINE 20 MG | Cancelled Post Market |
| 02197448 | APO-NIFED PA | APOTEX INC | Tablet (Extended-Release) | NIFEDIPINE 10 MG | Cancelled Post Market |
| 02236757 | DOM-NIFEDIPINE | DOMINION PHARMACAL | Capsule | NIFEDIPINE 5 MG | Cancelled Pre Market |
| 02236758 | DOM-NIFEDIPINE | DOMINION PHARMACAL | Capsule | NIFEDIPINE 10 MG | Cancelled Pre Market |
| 01946307 | GEN NIFEDIPINE CAP 10MG USP | GENPHARM ULC | Capsule | NIFEDIPINE 10 MG | Cancelled Post Market |
| 02471078 | MYLAN-NIFEDIPINE EXTENDED RELEASE | MYLAN PHARMACEUTICALS ULC | Tablet (Extended-Release) | NIFEDIPINE 20 MG | Cancelled Pre Market |
| 02156067 | NIFEDIPINE 10MG - CAP | SCHEIN PHARMACEUTICAL CANADA INC. | Capsule | NIFEDIPINE 10 MG | Cancelled Post Market |
| 02156059 | NIFEDIPINE 5MG - CAP | SCHEIN PHARMACEUTICAL CANADA INC. | Capsule | NIFEDIPINE 5 MG | Cancelled Post Market |
| 02229997 | NIFEDIPINE CAPSULES 10MG | PREMPHARM INC | Capsule | NIFEDIPINE 10 MG | Cancelled Post Market |
| 02442949 | NIFEDIPINE ER | SIVEM PHARMACEUTICALS ULC | Tablet (Extended-Release) | NIFEDIPINE 60 MG | Cancelled Post Market |
| 02442930 | NIFEDIPINE ER | SIVEM PHARMACEUTICALS ULC | Tablet (Extended-Release) | NIFEDIPINE 30 MG | Cancelled Post Market |
| 02421631 | NIFEDIPINE ER | PRO DOC LIMITEE | Tablet (Extended-Release) | NIFEDIPINE 30 MG | Dormant |
| 02211092 | NIFEDIPINE PA -10 - SRT 10MG | PRO DOC LIMITEE | Tablet (Extended-Release) | NIFEDIPINE 10 MG | Cancelled Post Market |
| 02154390 | NIFEDIPINE PA 10 - SRT 10MG | SCHEIN PHARMACEUTICAL CANADA INC. | Tablet (Extended-Release) | NIFEDIPINE 10 MG | Cancelled Post Market |
| 02154404 | NIFEDIPINE PA 20 - SRT 20MG | SCHEIN PHARMACEUTICAL CANADA INC. | Tablet (Extended-Release) | NIFEDIPINE 20 MG | Cancelled Post Market |
| 02211106 | NIFEDIPINE PA-20 - SRT 20MG | PRO DOC LIMITEE | Tablet (Extended-Release) | NIFEDIPINE 20 MG | Cancelled Post Market |
| 00782750 | NIFEDIPINE-10 CAP 10MG | PRO DOC LIMITEE | Capsule | NIFEDIPINE 10 MG | Cancelled Post Market |
| 00756830 | NOVO-NIFEDIN CAP 10MG | NOVOPHARM LIMITED | Capsule | NIFEDIPINE 10 MG | Cancelled Post Market |
| 02047462 | NOVO-NIFEDIN CAP 5MG | NOVOPHARM LIMITED | Capsule | NIFEDIPINE 5 MG | Cancelled Post Market |
| 02243472 | NOVO-NIFEDIN XL | NOVOPHARM LIMITED | Tablet (Extended-Release) | NIFEDIPINE 60 MG | Cancelled Pre Market |
| 02243471 | NOVO-NIFEDIN XL | NOVOPHARM LIMITED | Tablet (Extended-Release) | NIFEDIPINE 30 MG | Cancelled Pre Market |
| 02243470 | NOVO-NIFEDIN XL | NOVOPHARM LIMITED | Tablet (Extended-Release) | NIFEDIPINE 20 MG | Cancelled Pre Market |
| 00865591 | NU-NIFED CAP 10MG | NU-PHARM INC | Capsule | NIFEDIPINE 10 MG | Cancelled Post Market |
| 02200937 | NU-NIFEDIPINE-PA | NU-PHARM INC | Tablet (Extended-Release) | NIFEDIPINE 20 MG | Cancelled Post Market |
| 02212102 | NU-NIFEDIPINE-PA - PROLONGED ACTION TAB | NU-PHARM INC | Tablet (Extended-Release) | NIFEDIPINE 10 MG | Cancelled Post Market |
| 02235897 | PMS-NIFEDIPINE | PHARMASCIENCE INC | Capsule | NIFEDIPINE 5 MG | Cancelled Post Market |
| 02235898 | PMS-NIFEDIPINE | PHARMASCIENCE INC | Capsule | NIFEDIPINE 10 MG | Cancelled Post Market |
| 02440199 | PMS-NIFEDIPINE ER | PHARMASCIENCE INC | Tablet (Extended-Release) | NIFEDIPINE 20 MG | Cancelled Post Market |
| 02418630 | PMS-NIFEDIPINE ER | PHARMASCIENCE INC | Tablet (Extended-Release) | NIFEDIPINE 30 MG | Dormant |
| 02028638 | TARO-NIFEDIPINE CAP 10MG | TARO PHARMACEUTICALS INC | Capsule | NIFEDIPINE 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 33335 | 2024-05-30 | New Drug Submission (NDS) |
International API supply for NIFEDIPINE
9 valid EDQM Certificates of Suitability from 9 holders. 9 active FDA Drug Master Files.
Request a quote for SEAFORD NIFEDIPINE AND LIDOCAINE HYDROCHLORIDE CREAM